|
TYW1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.150840E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.031900E-04 |
| Normal-vs-Stage2 |
1.549880E-02 |
| Normal-vs-Stage3 |
5.61929999999267E-05 |
| Normal-vs-Stage4 |
2.76420000000499E-07 |
| Stage1-vs-Stage2 |
4.834000E-01 |
| Stage1-vs-Stage3 |
1.901630E-01 |
| Stage1-vs-Stage4 |
1.003310E-03 |
| Stage2-vs-Stage3 |
1.208180E-01 |
| Stage2-vs-Stage4 |
6.578800E-03 |
| Stage3-vs-Stage4 |
6.845500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.87050000000677E-05 |
| Normal-vs-AfricanAmerican |
3.580000E-01 |
| Normal-vs-Asian |
1.73122999999054E-05 |
| Caucasian-vs-AfricanAmerican |
1.572210E-02 |
| Caucasian-vs-Asian |
2.017000E-01 |
| AfricanAmerican-vs-Asian |
1.510120E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.42950000003861E-06 |
| Normal-vs-Female |
5.245600E-04 |
| Male-vs-Female |
1.478890E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.165480E-04 |
| Normal-vs-Age(41-60Yrs) |
1.019770E-04 |
| Normal-vs-Age(61-80Yrs) |
1.445530E-04 |
| Normal-vs-Age(81-100Yrs) |
9.537600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.890400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.292000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.954400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.559800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.586400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.665200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.119160E-01 |
| Classical-VS-Follicular |
4.570400E-01 |
| Classical-VS-Other |
5.678600E-01 |
| Classical-VS-Normal |
2.163900E-04 |
| Tall-VS-Follicular |
6.962200E-02 |
| Tall-VS-Other |
9.382600E-01 |
| Tall-VS-Normal |
3.71249999999712E-05 |
| Follicular-VS-Other |
4.862600E-01 |
| Follicular-VS-Normal |
2.739900E-03 |
| Other-VS-Normal |
5.907900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.367400E-04 |
| Normal-vs-N1 |
7.59970000263621E-08 |
| N0-vs-N1 |
1.950140E-04 |
|
|
